ArticleCancer immunology, immunotherapy : CII2021

PD-1/PD-L1 checkpoint inhibitors in combination with olaparib display antitumor activity in ovarian cancer patient-derived three-dimensional spheroid cultures.

Kathryn M Appleton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.